<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-methohexital.xml</id>
  <title>Recalls Watch: Methohexital</title>
  <link rel="self" href="https://recalls.watch/feed/substance-methohexital.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-10-08T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/n-par-health-issues-voluntary-nationwide-recall-two-lots-brevitalr-sodium-500-mgvi/</id>
    <title>Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-par-health-issues-voluntary-nationwide-recall-two-lots-brevitalr-sodium-500-mgvi/"/>
    <updated>2026-10-08T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter identified as cellulose</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99311/</id>
    <title>QuVa Pharma, Inc.: Methohexital Sodium</title>
    <link href="https://recalls.watch/recall/fda/99311/"/>
    <updated>2026-07-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/99220/</id>
    <title>ONESOURCE SPECIALTY PHARMA LIMITED: Methohexital Sodium for Injection</title>
    <link href="https://recalls.watch/recall/fda/99220/"/>
    <updated>2026-07-15T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications</summary>
  </entry>
</feed>
